A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages 192-197

  Laverman, Peter ^a   Dams, Els Th M ^b   Oyen, Wim J G ^b   Storm, Gert ^b   Koenders, Emile B ^b   Prevost, Richard ^b   Van Der Meer, Jos W M ^b   Corstens, Frans H M ^b   Boerman, Otto C ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

99mTc; Hydrazino nicotinyl; Imaging; Liposomes; Radiolabeling

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LIPOSOME; NICOTINE DERIVATIVE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ISOTOPE LABELING; KIDNEY TUBULE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ABSCESS; ANIMALS; DRUG CARRIERS; GAMMA CAMERAS; HINDLIMB; HYDRAZINES; LIPOSOMES; MALE; NIACINAMIDE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; TECHNETIUM; TECHNETIUM TC 99M EXAMETAZIME; TISSUE DISTRIBUTION;

EID: 0032953735     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Corstens FHM, Van der Meer JWM. Chemotactic peptides: new locomotion for imaging of infection? J Nucl Med. 1991;32:491-494.
2. Boerman OC, Storm G, Oyen WJG, et al. Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med. 1995;36:1639-1644.
3. Oyen WJG, Boerman OC, Storm G, et al. Detecting infection and inflammation with technetium-99m-labeled Stealth® liposomes. J Nucl Med. 1996;37:1392-1397.
4. Oyen WJG, Boerman OC, Storm G, et al. Labelled Stealth® liposomes in experimental infection: an alternative to leukocyte scintigraphy? Nucl Med Commun. 1996;17:742-748.
5. Boerman OC, Oyen WJG, Storm G, et al. Technetium-99m labelled liposomes to image experimental arthritis. Ann Rheum Dis. 1997;56:369-373.
6. 99mTc-labelled liposomes with Walker tumour cells in vitro. Liposome-mediated introduction of thaliblastine into resistant Walker tumour cells. Gen Pharmacol. 1983;14:407-411.
7. 99mTc) radiolabeled liposomes. J Microencapsul. 1989;6:105-113.
8. 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA. Nucl Med Biol. 1992;19:831-840.
9. Oku N, Namba Y, Takeda A, Okada S. Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes. Nucl Med Biol. 1993;20:407-412.
10. Goto R, Kubo H, Okada S. Liposomes prepared from synthetic amphiphiles. I. Their technetium labeling and stability. Chem Pharm Bull Tokyo. 1989;37:1351-1354.
11. Phillips WT, Rudolph AS, Goins B, Timmons JH, Klipper R, Blumhardt R. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl Med Biol. 1992;19:539-547.
12. Goins B, Klipper R, Rudolph AS, Cliff RO, Blumhardt R, Phillips WT. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J Nucl Med. 1993;34:2160-2168.
13. Goins B, Phillips WT, Klipper R. Blood-pool imaging using technetium-99m-labeled liposomes. J Nucl Med. 1996;37:1374-1379.
14. Abrams MJ, Juweid M, ten Kate CI, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med. 1990;31:2022-2028.
15. Babich JW, Solomon H, Pike MC, et al. Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J Nucl Med. 1993;34:1964-1974.
16. Claessens RAMJ, Boerman OC, Koenders EB, Oyen WJG, van der Meer JWM, Corstens FHM. Technetium-99m labelled hydrazinonicotinamide human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium labelled imunnoglobulin preparations. Eur J Nucl Med. 1996;23:414-421.
17. King TP, Zhao SW, Lam T. Preparation of protein conjugates via intermolecular hydrazone linkage. Biochemistry. 1986;25:5774-5779.
18. 99mTc-labelling of hydrazino nicotinamide modified proteins [abstract]. J Labelled Compd Radiopharm. 1994;35:1-2.
19. 99mTc. Bioconj Chem. 1997;8:155-160.
20. Hnatowitch DJ, Mardirossian G, Rusckowski M, Fogarasi, Virzi F, Winnard P Jr. Directly and indirectly technetium-99m-labeled antibodies - a comparison of in vitro and animal in vivo properties. J Nucl Med. 1993;34:109-119.
21. Boerman OC, Oyen WJG, van Bloois L, et al. Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. J Nucl Med. 1997;38:489-493.
22. Goins B, Klipper R, Phillips WT. Improved shelf stability of liposomes labeled with technetium-99m using the glutathione-HMPAO method [abstract]. J Nucl Med. 1997;38:179P.
23. 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl Med Biol. 1995;22:25-30.
24. Neirinkx RD, Canning LR, Piper IM, et al. Technetium-99m d,1-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med. 1987;28:191-202.
25. Verkade HJ, Derksen JT, Gerdirg A, Scherphof GL, Vonk RJ, Kuipers F. Differential hepatic processing and biliary secretion of head-group and acyl chains of liposomal phosphatidylcholines. Biochem J. 1991;275:139-144.